TELA Bio (TELA) EBT Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,879.00 |
| Dec 31, 2025 | -371.00 |
| Sep 30, 2025 | 739.00 |
| Jun 30, 2025 | 1,157.00 |
| Mar 31, 2025 | -22,626.00 |
| Dec 31, 2024 | 22,043.00 |
| Sep 30, 2024 | 2,359.00 |
| Jun 30, 2024 | -4,421.00 |
| Mar 31, 2024 | 4,605.00 |
| Dec 31, 2023 | -364.00 |
| Sep 30, 2023 | 395.00 |
| Jun 30, 2023 | 2,452.00 |
| Mar 31, 2023 | -1,364.00 |
| Dec 31, 2022 | 295.00 |
| Sep 30, 2022 | 1,309.00 |
| Jun 30, 2022 | 2,331.00 |
| Mar 31, 2022 | -2,825.00 |
| Dec 31, 2021 | 392.00 |
| Sep 30, 2021 | 183.00 |
| Jun 30, 2021 | 3,065.00 |
| Mar 31, 2021 | -382.00 |
| Dec 31, 2020 | 1,108.00 |
| Sep 30, 2020 | 2,644.00 |
| Jun 30, 2020 | 2,550.00 |
| Mar 31, 2020 | -6,006.00 |
| Dec 31, 2019 | -1,827.00 |
| Sep 30, 2019 | 3,817.00 |
| Jun 30, 2019 | 2,641.00 |
| Mar 31, 2019 | 7,378.00 |
| Dec 31, 2018 | -12,998.00 |